Nov 2026· Frontiers in Endocrinology· 0 citations· 47 references
Abstract
The C-reactive protein-triglyceride glucose index (CTI), as a novel marker reflecting insulin resistance (IR) and inflammation, has been investigated in various diseases. However, the association of CTI with carotid atherosclerosis (CA) in patients with type 2 diabetes mellitus (T2DM) remains unclear. This study aimed to investigate the association between CTI and CA, which was assessed by carotid plaque and intima-media thickness (IMT) in patients with T2DM.
This retrospective cross-sectional study analyzed 938 patients with T2DM. The CTI was calculated using the formula: 0.412×Ln[CRP (mg/L)]+Ln[(TG (mmol/L)×88.57×FPG (mmol/L)×18.02)/2]. Logistic regression models were adopted to analyze the connection of CTI with carotid plaque, and linear regression models were used to explore the association of CTI with carotid IMT. Receiver operating characteristic (ROC) curves, integrated discrimination improvement (IDI), and net reclassification improvement (NRI) were used to assess discrimination and reclassification of prevalent carotid plaque.
Among the 938 enrolled patients with T2DM, carotid plaques were detected in 438 participants (46.7%). Patients with carotid plaques had significantly higher CTI levels than those without plaques (9.98 ± 0.775 vs. 9.27 ± 0.664, P<0.001). After full adjustment, each one-unit increase in CTI was associated with higher odds of carotid plaque [odds ratio (OR) 4.189; 95% CI: 3.281-5.744; P<0.001] and greater carotid IMT (P = 0.016). When CTI was categorized into quartiles, compared with the lowest quartile, the highest quartile had an OR of 10.909 (95% CI: 6.982-17.521; P<0.001). The area under the ROC curve (AUC) showed superior discriminative performance of CTI for carotid plaque, with an AUC of 0.743, significantly higher than that of CRP (AUC 0.611; P<0.001) and the TyG index (AUC 0.655; P<0.001). When CTI was added to the base clinical model, the AUC increased from 0.737 to 0.820 (P<0.001), with an IDI of 13.5% and an NRI of 26.2%.
In patients with T2DM, elevated CTI levels are independently associated with the presence of carotid plaque and greater carotid IMT.
Abstract Introduction The C-reactive protein–triglyceride-glucose index (CTI) has emerged as an innovative biomarker for insulin resistance and inflammatory processes. Nevertheless, the association between CTI and diabetic vascular complications (DVCs) and its subtypes in individuals with diabetes remains unclear. Meth...
Shi-Kai Xiong, Hao Wang, Bin Wang et al.· BMJ public health· 0 citations
Background The composite index of inflammation and insulin resistance (IR), the C-reactive protein (CRP)–triglyceride–glucose (TyG) index (CTI), has been suggested to be closely associated with cardiovascular disease. However, the relationship between the CTI and kidney injury (KI), including its subtypes [declined kid...
Meng-Meng Fan, Xue-Ping Zhang, Xian-Wei Tian et al.· Journal of Inflammation Rese...· 0 citations
The present findings support the role of GLM7 as a composite metabolic marker correlated with hyperuricemia in patients with T2DM, but do not validate its use as a diagnostic or screening tool.
Zhang Y. J. Zheng, Qian-Yi Li, Hui-Juan Zhang· Frontiers in Endocrinology· 0 citations
Insulin resistance is a key mechanism in the development of atherosclerosis. The triglyceride–glucose (TyG) index is an easily obtainable surrogate of insulin resistance; however, its relationship with structural vascular damage in high-risk clinical settings remains insufficiently defined.
To investigate...
M. Koilakou, N. Ioakeimidis, E. Georgousi et al.· European Heart Journal· 0 citations
Background In patients with type 2 diabetes mellitus (T2DM), the Fibrosis-4 (FIB-4) index can be a simple indicator of vascular risk. This study aimed to assess the association between the FIB-4 index and subclinical vascular disease in patients with T2DM using mean carotid intima-media thickness (CIMT) as the primary...
Ahmad Farooq, Mohammed Mohsin Raza, N. Saeed et al.· Cureus· 0 citations
Objectives To analyze the association between the triglyceride glucose-body mass index (TyG-BMI) and diabetic kidney disease (DKD) in patients with type 2 Diabetes Mellitus (T2DM). Methods A single-center retrospective cross-sectional study was conducted enrolling 1,966 patients diagnosed with T2DM. General clinical da...
Si-Xu Xin, Xiao-Mei Zhang, Xin Zhao et al.· Frontiers in Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.